Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Moodys
Federal Trade Commission
Cantor Fitzgerald
Chinese Patent Office
Express Scripts
US Army
Farmers Insurance
Julphar
McKesson

Generated: December 11, 2017

DrugPatentWatch Database Preview

TAGAMET Drug Profile

« Back to Dashboard

Which patents cover Tagamet, and when can generic versions of Tagamet launch?

Tagamet is a drug marketed by Glaxosmithkline and Medtech Products and is included in six NDAs.

The generic ingredient in TAGAMET is cimetidine. There are twenty-five drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the cimetidine profile page.

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
GlaxosmithklineTAGAMETcimetidine hydrochlorideINJECTABLE;INJECTION017939-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Medtech ProductsTAGAMET HBcimetidineTABLET;ORAL020238-001Jun 19, 1995DISCNYesNo► Subscribe► Subscribe► Subscribe► Subscribe
GlaxosmithklineTAGAMETcimetidineTABLET;ORAL017920-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Medtech ProductsTAGAMET HBcimetidineTABLET;ORAL020238-002Aug 21, 1996OTCYesYes► Subscribe► Subscribe► Subscribe► Subscribe
GlaxosmithklineTAGAMETcimetidine hydrochlorideSOLUTION;ORAL017924-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
GlaxosmithklineTAGAMETcimetidineTABLET;ORAL017920-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
GlaxosmithklineTAGAMETcimetidineTABLET;ORAL017920-005Apr 30, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
GlaxosmithklineTAGAMETcimetidineTABLET;ORAL017920-004Dec 14, 1983DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
GlaxosmithklineTAGAMET HYDROCHLORIDE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINERcimetidine hydrochlorideINJECTABLE;INJECTION019434-001Oct 31, 1985DISCNYesNo► Subscribe► Subscribe► Subscribe► Subscribe
GlaxosmithklineTAGAMET HB 200cimetidineSUSPENSION;ORAL020951-001Jul 9, 1999DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: TAGAMET

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
GlaxosmithklineTAGAMETcimetidineTABLET;ORAL017920-003Approved Prior to Jan 1, 1982► Subscribe► Subscribe
GlaxosmithklineTAGAMETcimetidineTABLET;ORAL017920-005Apr 30, 1986► Subscribe► Subscribe
GlaxosmithklineTAGAMETcimetidine hydrochlorideINJECTABLE;INJECTION017939-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
GlaxosmithklineTAGAMETcimetidineTABLET;ORAL017920-003Approved Prior to Jan 1, 1982► Subscribe► Subscribe
GlaxosmithklineTAGAMETcimetidineTABLET;ORAL017920-004Dec 14, 1983► Subscribe► Subscribe
GlaxosmithklineTAGAMETcimetidineTABLET;ORAL017920-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
GlaxosmithklineTAGAMETcimetidine hydrochlorideSOLUTION;ORAL017924-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
GlaxosmithklineTAGAMETcimetidineTABLET;ORAL017920-004Dec 14, 1983► Subscribe► Subscribe
GlaxosmithklineTAGAMETcimetidineTABLET;ORAL017920-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
GlaxosmithklineTAGAMETcimetidineTABLET;ORAL017920-005Apr 30, 1986► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Dow
Merck
Teva
Baxter
UBS
US Army
McKinsey
Citi
Cipla
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot